GILD · News · 20260826N

Institutional Ownership Changes

GILEAD SCIENCES, INC. · 2026-08-26 · Importance 20 · Surprise 24

Ancora Advisors acquired 121,465 Gilead shares valued at approximately $15.35 million, while CastleArk Management acquired 527,542 shares valued at approximately $66.65 million. Canada Pension Plan Investment Board purchased 2.46 million shares valued at approximately $310.3 million, representing 0.20% of Gilead. Jupiter Topco acquired more than 3.5 million shares valued at approximately $448 million during the second quarter, and Man Group acquired 1,235,196 shares valued at approximately $156.06 million. Institutional investors collectively owned 83.67% of Gilead, according to the reported holdings.

Key facts

Gilead Sciences executives will present at three investor conferences in September 2026: the Wells Fargo Annual Healthcare Conference, the Cantor Global Healthcare Conference, and the Morgan Stanley Global Healthcare Conference. source
Gilead Sciences will make live webcasts of its September 2026 investor conference presentations available on the company's investors page, with replays accessible for at least 30 days. source
Ancora Advisors LLC acquired a new stake of 121,465 shares in Gilead Sciences, Inc., valued at approximately $15.35 million. source
Castleark Management LLC acquired a new position of 527,542 shares in Gilead Sciences, Inc., valued at approximately $66.65 million. source
The Canada Pension Plan Investment Board acquired 2,455,920 shares of Gilead Sciences, valued at approximately $310.3 million, representing 0.20% of the company. source
Quantbot Technologies LP acquired a new stake in Gilead Sciences, purchasing 11,342 shares valued at approximately $1,433,000. source
Roberts Glore & Co. Inc. IL purchased 9,885 shares of Gilead Sciences during the second quarter in a $1.25 million investment. source
Man Group plc acquired 1,235,196 shares of Gilead Sciences valued at approximately $156.06 million, representing about 0.10% of the company's stock. source